Ultrapower; a Minimally Invasive Tool for Evaluation of Total Cardiac Power
Ultrapower, an In-house Developed System for Instantaneous Logging of Ultrasound Based Blood Flow, Blood Pressure and ECG.
1 other identifier
interventional
28
1 country
1
Brief Summary
The heart is essentially a hydraulic pump which ensures adequate delivery of blood through generating pressure and forward flow of blood. The energy delivered by the heart is uncommonly measured clinically, and todays gold standard involves placing a plastic catheter into the lung arteries. The investigators have developed an ultrasound based approach to calculate this energy without the need for catheters through the heart. This novel approach is called ultrapower. Ultrapower involves the instantaneous multiplication of the cardiac output and the arterial blood pressure. The study aims to use the ultrasound based approach to investigate Cardiac Power in the coronary artery bypass graft population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2016
CompletedFirst Posted
Study publicly available on registry
April 4, 2016
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMarch 27, 2019
March 1, 2019
6 months
March 17, 2016
March 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method
Measured both as ultrapower and cardiac power output, both measured in watts and method of measurement described in intervention section
Immediately preoperatively
The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method
approximately 1 hour post operatively
The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method
1 day after operation
Study Arms (1)
Postoperative elective CABG patients
OTHERPatients included for coronary artery bypass graft (CABG) surgery, secondary to ischaemic heart disease.
Interventions
The intervention is a comparison between two methods of calculating the heart's energy delivery, cardiac power, measured in watts. A tertiary measurement is calculation of arterioventricular coupling. All patients will have cardiac power output calculated through the use of Doppler echocardiography. The echocardiography based cardiac output will be done through the velocity time integral of the left ventricular outflow tract (LVOT). This will be compared against total power as measured by our Ultrapower approach which involves instantaneous doppler measurement of cardiac output through LVOT multiplied with simultaneous radial artery pressure. This and ejection fraction (for calculation of ventriculoarterial coupling) will be recorded at rest in neutral position preoperatively, directly post operatively and the day after operation. Directly postoperatively the power measurements will also be repeated in Trendelenburg and anti Trendelenburg position.
Eligibility Criteria
You may qualify if:
- coronary artery bypass graft operation
You may not qualify if:
- Lack of informed consent
- Previous aortic valve replacement
- Inadequate Doppler signal on transthoracic echocardiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
Study Sites (1)
Department of cardiothoracic surgery
Trondheim, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Idar Kirkeby-Garstad, md phd
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2016
First Posted
April 4, 2016
Study Start
June 1, 2016
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
March 27, 2019
Record last verified: 2019-03